Ticagrelor – toward more efficient platelet inhibition and beyond
Sign Up to like & getrecommendations! Published in 2018 at "Therapeutics and Clinical Risk Management"
DOI: 10.2147/tcrm.s152369
Abstract: Novel antiplatelet drugs, including ticagrelor, are being successively introduced into the therapy of atherothrombotic conditions due to their superiority over a standard combination of clopidogrel with acetylsalicylic acid in patients with acute coronary syndromes (ACS).… read more here.
Keywords: platelet inhibition; ticagrelor; ticagrelor toward; efficient platelet ... See more keywords